Keywords: Johnson & Johnson, Jansse, Bayer, Bioseal Biotech, Xarelto, USA, FDA, DVT, PE, VTE, Plasma-derived biologicals, China

J&J's Janssen files Xarelto with FDA for new indication; buys Chinese firm

Article | 03 May 2012

Print This

US health care major Johnson & Johnson’s (NYSE: JNJ) subsidiary Janssen Research & Development says it has submitted ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in